The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 63 | 13.9x | 20.1x | Near average | |
Growth | 52 | 8.4% | 5.6% | Near average | |
Quality | 54 | 8.3% | 7.6% | Near average | |
Safety | 48 | 2.1x | 0.4x | Near average | |
Capital Return | 84 | — | 2.19% | Above average | |
Momentum | 64 | — | — | Near average | |
Sentiment | 82 | — | — | Above average |
Nutrien Ltd. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Nutrien Ltd. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Nutrien stock has seen a significant upward revision in analyst estimates, as the average price target jumped by 16.67% to reach 84 dollars compared to 72 dollars a month ago. This change reflects growing optimism supported by recent upgrades from major institutions such as Wells Fargo and Jefferies, which raised their ratings for the stock to "Overweight" and "Buy" respectively during March.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.